OCDXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (1 1月 1970 @ 09:00):

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide...

Stats
本日の出来高	789 491
平均出来高	1.01M
時価総額	0.00
EPS	$0.0612 ( 2022-05-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-42.28
ATR14	$0.509 (2.89%)

Insider Trading

Date	Person	Action	Amount	type
2022-05-27	Perez David Brian	Sell	8 576	Ordinary Shares, $0.00001 par value
2022-05-27	Hull Carl	Sell	41 172	Ordinary Shares, $0.00001 par value
2022-05-27	Dilsaver Evelyn S	Sell	5 200	Ordinary Shares, $0.00001 par value
2022-05-27	Carlyle Partners Vi Cayman Holdings, L.p.	Sell	118 106 000	Ordinary Shares, $0.00001 par value
2022-05-27	Carlyle Group Inc.	Sell	118 106 000	Ordinary Shares, $0.00001 par value

INSIDER POWER
-100.00
Last 11 transactions
Buy: 10 400 \| Sell: 261 566 948

ボリューム相関

長: 0.02 (neutral)

短: -0.22 (neutral)

Signal:(49.304) Neutral

Ortho Clinical 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Ortho Clinical 相関 - 通貨/商品

0.18
( neutral )

0.13
( neutral )

0.00
( neutral )

0.33
( neutral )

-0.08
( neutral )

0.08
( neutral )

Ortho Clinical 財務諸表

Annual	2021
収益:	$2.04B
総利益:	$1.04B (50.71 %)
EPS:	$-0.0382

FY	2021
収益:	$2.04B
総利益:	$1.04B (50.71 %)
EPS:	$-0.0382

FY	2020
収益:	$1.77B
総利益:	$858.00M (48.58 %)
EPS:	$-0.978

FY	2019
収益:	$1.80B
総利益:	$879.10M (48.80 %)
EPS:	$-0.710

Financial Reports:

No articles found.

Ortho Clinical

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.